Resultados de búsqueda - ((((este OR restored) OR (((best OR meta) OR meta) OR waste)) OR wester) OR est) point~

  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96

    The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type... por Yale, Jean François, Pettus, Jeremy Hodson, Brito Sanfiel, Miguel, Lavalle González, Fernando Javier, Merino Trigo, Ana, Stella, Peter, Chevalier, Soazig, Buzzetti, Raffaella

    Publicado 2018
    “…Abstract Aims To evaluate the effect of concomitant dipeptidyl peptidase IV inhibitor (DPPIVi) use on efficacy and safety of insulin glargine 300 U/mL (Gla-300) versus glargine 100 U/mL (Gla-100) in people with type 2 diabetes on oral antihyperglycaemic drugs. Methods A post hoc patient-level meta-analysis was performed using data from EDITION 2 (basal insulin [N = 811]) and EDITION 3 (insulin-naïve [N = 878]), multicentre, randomised, openlabel, parallel-group, phase 3a trials of similar design. …”
    Enlace del recurso
    Artículo
  17. 97
  18. 98
  19. 99
  20. 100

Herramientas de búsqueda: